Quantifying biotherapeutics in biological matrices plays a critical role in the drug discovery and development process. Ligand binding assays often lack the sensitivity to detect low-concentration analytes, particularly with limited sample supply. Scientists in bioanalytical laboratories routinely use liquid chromatography with tandem mass spectrometry (LC-MSMS) to complement traditional ligand binding assays.
In this webinar sponsored by SCIEX, Lei Xiong will discuss how SCIEX’s Triple Quad™ 7500 LC-MS/MS System improves assay sensitivity for in-matrix quantification of various types of biotherapeutics, including monoclonal antibodies, cyclic peptides, and oligonucleotides.
Topics to be covered
Lei Xiong, PhD
Biopharma application manager, North America